Sign in

CIK 0001572616

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

FRACTYL HEALTH, INC.

Sign in to watch
Ticker
GUTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273553477
Phone
+1 781-902-8800
Business address
3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA, 01803
Former names
Fractyl Laboratories Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Planned sale Chief Executive Officer sold 111,920 shares at an average $1.84 ($206,003)
  3. 4 Planned sale President, Chief Product Off. sold 43,818 shares at an average $1.88 ($82,266)
  4. 4 Open-market sale Chief Executive Officer sold 96,517 shares at $2.47 ($238,358)
  5. 4 Open-market sale President, Chief Product Off. sold 64,197 shares at $2.47 ($158,541)
  6. 4 Open-market sale President, Chief Product Off. sold 65,000 shares at $2.90 ($188,474)
  7. 3/A Insider 3/A
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Conversion 10% owner acquired 4,770,901 shares (conversion)
  11. 4 Conversion 10% owner acquired 1,339,261 shares (conversion)
  12. 4 Conversion 10% owner acquired 673,391 shares (conversion)
  13. 4 Conversion 10% owner acquired 283,878 shares (conversion)
  14. 4 Conversion Director acquired 277,890 shares (conversion)
  15. 4 Open-market buy Director bought 333,333 shares at $15.00 ($4,999,995)
  16. 4 Conversion President, Chief Product Off. acquired 142,109 shares (conversion)
  17. 4 Conversion Chief Executive Officer acquired 9,318 shares (conversion)
  18. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  19. 4 Conversion 10% owner acquired 4,800,310 shares (conversion)
  20. 4 Open-market buy Director bought 466,666 shares at $15.00 ($6,999,990)

Page 3 of 5 · 91 filings